van Kesteren, Z. http://orcid.org/0000-0003-3200-800X
van der Horst, A.
Gurney-Champion, O. J.
Bones, I.
Tekelenburg, D.
Alderliesten, T.
van Tienhoven, G.
Klaassen, R.
van Laarhoven, H. W. M.
Bel, A.
Article History
Received: 2 October 2018
Accepted: 22 April 2019
First Online: 14 May 2019
Ethics approval and consent to participate
: Written informed consent was given by all healthy volunteers and patients. The institutional ethics committee granted an exemption from requiring ethics approval for the procedures described in this study of healthy volunteers (W15_373; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands). Written informed consent was obtained from all participants prior to the MR examinations. The ethics committee approved the study including patients.
: Figures depicting individual person’s data are unidentifiable and there are no details on individuals reported within the manuscript. Therefore, separate consent for publication is not deemed necessary for the figures shown this manuscript.
: H.L. has an advisory role for BMS, Lilly and Nordic Pharma. She has received research funding from Bayer, BMS, Celgene, Janssen, Lilly, Nordic Pharma, Philips and Roche. A.B. does consultancy work for Elekta and is project leader of several Elekta-sponsored projects outside of this work. T.A. is involved in projects supported by Elekta. These companies had no involvement in study design, data collection and analysis, or writing of the manuscript. The other authors have no relevant conflicts of interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.